ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1962

Utilization of Telehealth Among Patients with Rheumatic Diseases in the Early Months of the COVID-19 Pandemic

Kristin Wipfler1, Yomei Shaw2, Teresa Simon3, Adam Cornish1, Patricia Katz4 and Kaleb Michaud5, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, East Lansing, MI, 3Bristol-Myers Squibb Company (at time of analysis), Princeton, NJ, 4University of California, San Francisco, Novato, CA, 5University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2020

Keywords: Access to care, COVID-19, Health Care, quality of care, registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Health Services Research (1958–1962)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Many health care providers replaced in-person clinical visits with telehealth visits or expanded their telehealth offerings due to the COVID-19 pandemic. We sought to better understand the frequency of these changes and satisfaction with telehealth appointments among patients with rheumatic diseases during the first months of the COVID-19 pandemic in the US.

Methods: The study population included participants in FORWARD, The National Databank for Rheumatic Diseases who completed a supplemental COVID-19 questionnaire between May 20 and June 2, 2020. Respondents were asked about the number of telehealth appointments they had between March 1, 2020 and the date of questionnaire completion. If they had at least one telehealth appointment, they were asked to rate their satisfaction with the appointment(s) on a Likert scale. Logistic regression models were used to identify factors associated with having telehealth appointments and with telehealth satisfaction. Respondents’ optional free text comments were qualitatively analyzed to assess reasons for satisfaction/dissatisfaction with telehealth.

Results: A total of 1,213 participants were included in this study, with 617 (51%) reporting at least one telehealth appointment between March 1, 2020 and questionnaire completion. Of those who had at least one telehealth appointment, 447 (72%) reported being “somewhat satisfied” or “very satisfied” with their appointment(s) (Table 1). Satisfaction appeared to decrease as the number of telehealth appointments increased (Table 2; Χ2 p=0.01) but this was attenuated when considering demographic and clinical covariates. Younger age, higher Rheumatic Disease Comorbidity Index (RDCI), higher PAS-II, and prednisone use were associated with having at least one telehealth appointment (Figure 1A). Lower education level and SLE diagnosis (with OA as the comparator) were associated with lower satisfaction with telehealth (Figure 1B). In the free text comments, respondents were satisfied with telehealth because it was safer, saved travel time, enabled continued access to services, and provided help with COVID-19 symptoms. Respondents reported dissatisfaction with telehealth due to technical difficulties, perceptions that telehealth visits were less useful than in-person visits, and not being able to get needed services through telehealth.

Conclusion: About half of rheumatology patients in this cohort reported having one or more telehealth appointments during the first several months of the COVID-19 pandemic in the US, and most of them were satisfied with the appointment(s). Utilization of telehealth has expanded dramatically in a short period of time, with those with the greatest need (comorbidities and high disease activity) most likely to use these services. As clinics adapt to having more telehealth visits, it will be important to ensure quality of care and satisfaction is met for populations that are most at risk.

Table 1. Demographics and clinical characteristics of participants who did and did not have telehealth appointments, and of those who were and were not satisfied with telehealth. Values are mean (SD) or %.

Table 2. Satisfaction with telehealth appointments by number of telehealth appointments reported. Values are n (%).

Figure 1. Factors associated with having one or more telehealth appointments (A) and with patient satisfaction with telehealth (B). OA was the comparator for diagnosis. Statistically significant covariates are labeled with an asterisk (*).


Disclosure: K. Wipfler, None; Y. Shaw, None; T. Simon, Bristol Myers Squibb, 5, Lexicon, 5; A. Cornish, None; P. Katz, None; K. Michaud, Rheumatology Research Foundation, 2.

To cite this abstract in AMA style:

Wipfler K, Shaw Y, Simon T, Cornish A, Katz P, Michaud K. Utilization of Telehealth Among Patients with Rheumatic Diseases in the Early Months of the COVID-19 Pandemic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/utilization-of-telehealth-among-patients-with-rheumatic-diseases-in-the-early-months-of-the-covid-19-pandemic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utilization-of-telehealth-among-patients-with-rheumatic-diseases-in-the-early-months-of-the-covid-19-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology